BODIPY-based fluorescent liposomes with sesquiterpene lactone trilobolide
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F61388963%3A_____%2F17%3A00476521" target="_blank" >RIV/61388963:_____/17:00476521 - isvavai.cz</a>
Alternative codes found
RIV/61389030:_____/17:00476521 RIV/68378041:_____/17:00476521 RIV/00216208:11140/17:10366002 RIV/60461373:22330/17:43913135 RIV/60461373:22310/17:43913135
Result on the web
<a href="http://dx.doi.org/10.3762/bjoc.13.128" target="_blank" >http://dx.doi.org/10.3762/bjoc.13.128</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.3762/bjoc.13.128" target="_blank" >10.3762/bjoc.13.128</a>
Alternative languages
Result language
angličtina
Original language name
BODIPY-based fluorescent liposomes with sesquiterpene lactone trilobolide
Original language description
Like thapsigargin, which is undergoing clinical trials, trilobolide is a natural product with promising anticancer and anti-inflammatory properties. Similar to thapsigargin, it has limited aqueous solubility that strongly reduces its potential medicinal applications. The targeted delivery of hydrophobic drugs can be achieved using liposome-based carriers. Therefore, we designed a traceable liposomal drug delivery system for trilobolide. The fluorescent green-emitting dye BODIPY, cholesterol and trilobolide were used to create construct 6. The liposomes were composed of dipalmitoyl-3-trimethylammoniumpropane and phosphatidylethanolamine. The whole system was characterized by atomic force microscopy, the average size of the liposomes was 150 nm in width and 30 nm in height. We evaluated the biological activity of construct 6 and its liposomal formulation, both of which showed immunomodulatory properties in primary rat macrophages. The uptake and intracellular distribution of construct 6 and its liposomal formulation was monitored by means of live-cell fluorescence microscopy in two cancer cell lines. The encapsulation of construct 6 into the liposomes improved the drug distribution in cancer cells and was followed by cell death. This new liposomal trilobolide derivative not only retains the biological properties of pure trilobolide, but also enhances the bioavailability, and thus has potential for the use in theranostic applications.
Czech name
—
Czech description
—
Classification
Type
J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database
CEP classification
—
OECD FORD branch
10401 - Organic chemistry
Result continuities
Project
Result was created during the realization of more than one project. More information in the Projects tab.
Continuities
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace
Others
Publication year
2017
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
Beilstein Journal of Organic Chemistry
ISSN
1860-5397
e-ISSN
—
Volume of the periodical
13
Issue of the periodical within the volume
JUL 4
Country of publishing house
DE - GERMANY
Number of pages
9
Pages from-to
1316-1324
UT code for WoS article
000405427300001
EID of the result in the Scopus database
2-s2.0-85023616975